Classic Electrod (CLASSICEIL)

Score breakdown: P/E: 3/3 · ROCE: 1/2 · Growth: 1/2 · Dividend: 0/1

Key Financials

Strengths

• P/E of 6.89 and PEG of 0.64 provide a margin of safety if earnings can hold or grow.
• ROCE of 22.34% indicates strong capital efficiency relative to competitors.
• Piotroski F-Score of 7/9 suggests generally sound fundamentals and minimal red flags.
• Promoter holding of 73.44% aligns management interests with minority shareholders.
• Sales growth of 15.74% shows healthy demand for the business.

Concerns

• Profit growth of 5.70% trails sales growth of 15.74%, pointing to margin compression.
• Dividend yield is 0.00%, so investors receive no income while waiting.
• Missing book value, ROE, and debt/equity data limits a proper Graham-style safety assessment.
• Market cap of only ₹83 Cr implies low liquidity and higher volatility risk.

AI Analysis

At first glance, Classic Electrod offers the kind of numbers Graham would circle: a P/E of 6.89, a market cap of only ₹83 Cr, and a Piotroski F-Score of 7/9. But I have learned to dig before I celebrate. Sales grew 15.74%, yet profit grew only 5.70%. That divergence tells me margins are under pressure. The latest quarter shows sales of ₹122 Cr and net profit of ₹6 Cr, a net margin of roughly 4.9% — a thin, competitive industrial business. ROCE of 22.34% is genuinely good, and a Piotroski score of 7 suggests the balance sheet is not deteriorating. Still, with no book value, ROE, or debt/equity disclosed, I cannot fully assess financial risk. The dividend yield is zero, so the only return is the business itself. The PEG of 0.64 and P/E of 6.89 make it look cheap if earnings can grow. But 5.70% profit growth is not exciting, and if sales growth is 15.74%, profit should be growing faster, not slower. Perhaps this is a cyclical enjoying a good year. Promoter holding at 73.44% is a positive: owners are aligned. But low float can make the stock volatile. I would not call this a wide-moat stalwart. It is a small, capital-efficient industrial company selling at an attractive multiple, with decent health signals and execution questions. I need to see profit margins stabilize and improve before committing. If the company can convert its sales growth into earnings growth, the low P/E and PEG make this potentially rewarding. If not, the cheapness may simply be the market correctly pricing stagnation.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer